Cambridge Investment Research Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-59,825
| Closed | -$5K | – | 3311 |
|
|
2022
Q4 | $5K | Sell |
59,825
-9,000
| -13% | -$752 | ﹤0.01% | 3087 |
|
|
2022
Q3 | $9K | Hold |
68,825
| – | – | ﹤0.01% | 3027 |
|
|
2022
Q2 | $20K | Sell |
68,825
-1,421
| -2% | -$413 | ﹤0.01% | 3000 |
|
|
2022
Q1 | $22K | Buy |
70,246
+10,211
| +17% | +$3.2K | ﹤0.01% | 3120 |
|
|
2021
Q4 | $138K | Sell |
60,035
-11,990
| -17% | -$27.6K | ﹤0.01% | 2978 |
|
|
2021
Q3 | $166K | Buy |
72,025
+23,300
| +48% | +$53.7K | ﹤0.01% | 2854 |
|
|
2021
Q2 | $267K | Buy |
48,725
+12,700
| +35% | +$69.6K | ﹤0.01% | 2561 |
|
|
2021
Q1 | $189K | Buy |
+36,025
| New | +$189K | ﹤0.01% | 2645 |
|
|
2015
Q1 | – | Sell |
-1,125
| Closed | -$6K | – | 1462 |
|
|
2014
Q4 | $6K | Buy |
1,125
+375
| +50% | +$2K | ﹤0.01% | 1362 |
|
|
2014
Q3 | $7K | Hold |
750
| – | – | ﹤0.01% | 1458 |
|
|
2014
Q2 | $7K | Hold |
750
| – | – | ﹤0.01% | 1336 |
|
|
2014
Q1 | $10K | Hold |
750
| – | – | ﹤0.01% | 1290 |
|
|
2013
Q4 | $18K | Sell |
750
-5
| -0.7% | -$120 | ﹤0.01% | 1226 |
|
|
2013
Q3 | $24K | Hold |
755
| – | – | ﹤0.01% | 1185 |
|
|
2013
Q2 | $24K | Buy |
+755
| New | +$24K | ﹤0.01% | 1093 |
|